Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Advances in Gastroenterology: From Coeliac Disease to Crohns Therapies
This episode covers the latest in gastroenterology research, including updated guidelines for coeliac disease and peptic ulcers, novel treatments for Crohn's disease and hepatocellular carcinoma, and innovative diagnostic approaches.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.
Authors: Al-Toma A, Volta U, Auricchio R, et al.
Journal: United European gastroenterology journal, 2019 Jun
PMID: 31210940
DOI: 10.1177/2050640619844125
2. Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
Authors: Loftus EV Jr, Panés J, Lacerda AP, et al.
Journal: The New England journal of medicine, 2023 May 25
PMID: 37224198
DOI: 10.1056/NEJMoa2212728
3. Diagnostic potential of total serum ghrelin in autoimmune gastritis: A systematic review and meta-analysis.
Authors: Taufiqqurrachman I, Witarto AP, Syam AF, et al.
Journal: PloS one, 2026
PMID: 41818289
DOI: 10.1371/journal.pone.0344129
4. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations.
Authors: Ni Y, Qian L, Siliceo SL, et al.
Journal: Cell metabolism, 2023 Sep 5
PMID: 37673036
DOI: 10.1016/j.cmet.2023.08.002
5. Advanced imaging (narrow band and acetic acid chromoendoscopy) and guided biopsies in surveillance of Barrett's oesophagus: a systematic review.
Authors: Gamakaranage C, Butler TD, Ratcliffe E, et al.
Journal: BMJ open gastroenterology, 2026 Mar 13
PMID: 41825912
DOI: 10.1136/bmjgast-2025-002157
6. Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial).
Authors: Sanduzzi-Zamparelli M, Matilla A, Lledo JL, et al.
Journal: Alimentary pharmacology & therapeutics, 2026 Apr
PMID: 41725391
DOI: 10.1111/apt.70578
7. Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
Authors: Loftus EV Jr, Panés J, Lacerda AP, et al.
Journal: The New England journal of medicine, 2023 May 25
PMID: 37224198
DOI: 10.1056/NEJMoa2212728
8. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Authors: Kamada T, Satoh K, Itoh T, et al.
Journal: Journal of gastroenterology, 2021 Apr
PMID: 33620586
DOI: 10.1007/s00535-021-01769-0
9. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Authors: Kamada T, Satoh K, Itoh T, et al.
Journal: Journal of gastroenterology, 2021 Apr
PMID: 33620586
DOI: 10.1007/s00535-021-01769-0
10. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Authors: Kamada T, Satoh K, Itoh T, et al.
Journal: Journal of gastroenterology, 2021 Apr
PMID: 33620586
DOI: 10.1007/s00535-021-01769-0
Authors: Al-Toma A, Volta U, Auricchio R, et al.
Journal: United European gastroenterology journal, 2019 Jun
PMID: 31210940
DOI: 10.1177/2050640619844125
2. Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
Authors: Loftus EV Jr, Panés J, Lacerda AP, et al.
Journal: The New England journal of medicine, 2023 May 25
PMID: 37224198
DOI: 10.1056/NEJMoa2212728
3. Diagnostic potential of total serum ghrelin in autoimmune gastritis: A systematic review and meta-analysis.
Authors: Taufiqqurrachman I, Witarto AP, Syam AF, et al.
Journal: PloS one, 2026
PMID: 41818289
DOI: 10.1371/journal.pone.0344129
4. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations.
Authors: Ni Y, Qian L, Siliceo SL, et al.
Journal: Cell metabolism, 2023 Sep 5
PMID: 37673036
DOI: 10.1016/j.cmet.2023.08.002
5. Advanced imaging (narrow band and acetic acid chromoendoscopy) and guided biopsies in surveillance of Barrett's oesophagus: a systematic review.
Authors: Gamakaranage C, Butler TD, Ratcliffe E, et al.
Journal: BMJ open gastroenterology, 2026 Mar 13
PMID: 41825912
DOI: 10.1136/bmjgast-2025-002157
6. Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial).
Authors: Sanduzzi-Zamparelli M, Matilla A, Lledo JL, et al.
Journal: Alimentary pharmacology & therapeutics, 2026 Apr
PMID: 41725391
DOI: 10.1111/apt.70578
7. Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
Authors: Loftus EV Jr, Panés J, Lacerda AP, et al.
Journal: The New England journal of medicine, 2023 May 25
PMID: 37224198
DOI: 10.1056/NEJMoa2212728
8. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Authors: Kamada T, Satoh K, Itoh T, et al.
Journal: Journal of gastroenterology, 2021 Apr
PMID: 33620586
DOI: 10.1007/s00535-021-01769-0
9. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Authors: Kamada T, Satoh K, Itoh T, et al.
Journal: Journal of gastroenterology, 2021 Apr
PMID: 33620586
DOI: 10.1007/s00535-021-01769-0
10. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Authors: Kamada T, Satoh K, Itoh T, et al.
Journal: Journal of gastroenterology, 2021 Apr
PMID: 33620586
DOI: 10.1007/s00535-021-01769-0
